Luke Freeman-Mills
- Oncology
- Obstetrics and Gynecology top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Reproductive Medicine top 5%
- Co-authors
- Carien L. CreutzbergHans W. NijmanTjalling BosseMarco de BruynFlorine A. EgginkInge C. van GoolDavid N. ChurchIan Tomlinson
- Topics
- Endometrial and Cervical Cancer Treatments (4 papers)Cancer Genomics and Diagnostics (3 papers)Cancer Immunotherapy and Biomarkers (3 papers)
- Partner nations
- United KingdomNetherlandsAustralia
In The Last Decade
Luke Freeman-Mills
7 papers receiving 487 citations
Peers
Comparison fields: 5 of 39
- Oncology 197
- Obstetrics and Gynecology 191
- Molecular Biology 175
- Pathology and Forensic Medicine 137
- Reproductive Medicine 113
Countries citing papers authored by Luke Freeman-Mills
This map shows the geographic impact of Luke Freeman-Mills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Freeman-Mills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Freeman-Mills more than expected).
Fields of papers citing papers by Luke Freeman-Mills
This network shows the impact of papers produced by Luke Freeman-Mills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Freeman-Mills. The network helps show where Luke Freeman-Mills may publish in the future.
Co-authorship network of co-authors of Luke Freeman-Mills
This figure shows the co-authorship network connecting the top 25 collaborators of Luke Freeman-Mills. A scholar is included among the top collaborators of Luke Freeman-Mills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Freeman-Mills. Luke Freeman-Mills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition | 17 |
| 3 | 101 | |
| 4 | 231 | |
| 5 | 24 | |
| 6 | 34 | |
| 7 | 73 |
About Luke Freeman-Mills
Luke Freeman-Mills is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Physiology, having authored 7 papers that have together received 492 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (4 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Obstetrics and Gynecology (191 citations), Reproductive Medicine (113 citations) and Pathology and Forensic Medicine (137 citations). Luke Freeman-Mills has collaborated with scholars based in United Kingdom, Netherlands and Australia. Frequent co-authors include Carien L. Creutzberg, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn, Florine A. Eggink, Inge C. van Gool, David N. Church, Ian Tomlinson, Vincent T.H.B.M. Smit and Cor D. de Kroon. Their work appears in journals such as Clinical Cancer Research, British Journal of Cancer and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.